Cancer News and Research

Latest Cancer News and Research

FoP in patients with chronic arthritis or cancer: Group psychotherapy may help

A controlled study by a group of German investigators published in the current issue of Psychotherapy and Psychosomatics indicates that brief group psychotherapy is helpful for clearing fears of disease progression (FoP) in patients with chronic arthritis or cancer. The interventions comprised either cognitive-behavioral group therapy or supportive-experiential group therapy. The investigators tested whether these generic interventions would prove effective in different illness types.

10 Feb 2010

Biology of lung cancer varies by age and gender

The biology of lung cancer differs from one patient to the next, depending on age and sex, according to scientists at Duke University Medical Center. The findings may help explain why certain groups of patients do better than others, even though they appear to have the same disease.

10 Feb 2010

NYBC calls for blood donation to meet winter needs

New York Blood Center (NYBC) serving New York City, Long Island, Hudson Valley and New Jersey calls upon the community to please donate blood and platelets, as the tri-state area braces for a huge predicted winter snowstorm. Healthy people of all blood types and ethnicities are encouraged to donate this week.

10 Feb 2010

VSV has potential to be genetically modified to serve as anti-cancer agent

Vesicular stomatitis virus, or VSV, has long been a model system for studying and understanding the life cycle of negative-strand RNA viruses, which include viruses that cause influenza, measles and rabies.

10 Feb 2010

Researchers find that mutation in single gene can cause endometrial cancer

A mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy, researchers at UT Southwestern Medical Center have found in an animal study.

10 Feb 2010

Comcast and SU2C launch initiative to raise funds for cancer research

Comcast Corporation and Stand Up To Cancer (SU2C) have launched the second installment of musical assets for Stand Up 2 Cancer On Demand, the first-ever video-on-demand (VOD) initiative focused on broadening awareness and raising funds for innovative cancer research, which debuted on Comcast in December.

10 Feb 2010

NCCS joins CoC to reduce morbidity and mortality of cancer

The National Coalition for Cancer Survivorship (NCCS) has accepted an invitation to join the Commission on Cancer (CoC), a multidisciplinary organization administered by the American College of Surgeons dedicated to reducing the morbidity and mortality of cancer through education, standards setting, and the monitoring of quality of care.

10 Feb 2010

UnitedHealthcare launches OCA program for cancer patients

UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, launched its Oncology Care Analysis (OCA) program. This patient-focused, integrated program uses a first-of-its-kind database that combines clinical and claims data to gauge the quality of cancer patient care based on approved treatment guidelines from the National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers.

10 Feb 2010

Study may pave way for more refined treatments for brain tumors

Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.

10 Feb 2010

Researchers find link between prevalence of diabetes and neighborhood socioeconomic status

Researchers from Boston University's Slone Epidemiology Center have found a direct link between neighborhood socioeconomic status and risk for type 2 diabetes in African American women.

10 Feb 2010

Soft drinks increase risk of developing pancreatic cancer

Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly two-fold compared with individuals who did not consume soft drinks, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

10 Feb 2010

Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnostic tests

Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).

10 Feb 2010

Study shows lactobacillus is effective in improving H. pylori-infected diseases

Helicobacter pylori (H. pylori) are considered to be the most important etiological agents of chronic gastritis. The eradication of H. pyloridepends on the combination of antibiotics and acid suppression drugs.

10 Feb 2010

Researchers publish findings that may lead to new standard of care for cervical cancer patients

Researchers at the Ireland Cancer Center of University Hospitals (UH) Case Medical Center, have published new findings that may lead to a new standard of care for patients with locally advanced cervical cancer.

10 Feb 2010

Dana-Farber Cancer Institute, Sanford-Burnham Medical Research Institute sign license agreement with Genentech, Roche

Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses.

10 Feb 2010

Research suggests a potential means of circumventing drug resistance in breast cancer patients

Overexpression of low-molecular-weight (LMW-E) forms of the protein cyclin E renders the aromatase inhibitor letrozole ineffective among women with estrogen-receptor-positive (ER+) breast cancers, researchers from The University of Texas M. D. Anderson Cancer Center report in Clinical Cancer Research.

10 Feb 2010